TEXAS INSTRUMENT INC (TXN)
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for TXN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TXN | Former chairman and chief executive officer of Humacyte, Inc. | 68 | ["Management responsibility of a large multinational company operating in a regulated industry","Responsibility for significant capital and R&D investments"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Former chairman and chief executive officer of Humacyte, Inc. Independent director Age 68 Director since 2004 Career highlights Ms. Cox was the executive chair of Humacyte, Inc. from 2018 to 2019, where she was also chairman and chief executive officer from 2010 to 2018. Prior to Humacyte, Ms. Cox held several senior management positions in the medical industry, including leading the global pharmaceuticals business at Schering-Plough Corporation and the global prescription business at Pharmacia Corporation. She also serves as interim executive chair of Organon & Co. Key skills and experience Management responsibility of a large multinational company operating in a regulated industry Responsibility for significant capital and R&D investments Other current public company directorships Organon & Co. Solventum Corporation Other public company directorships in the last five years Cardinal Health, Inc. Cartesian Therapeutics, Inc.